What is Apyx?
Apyx Medical operates as a specialized manufacturer of advanced energy solutions, primarily serving the cosmetic surgery and broader medical technology landscape. The company distinguishes itself through the development of proprietary medical devices engineered to meet the rigorous demands of modern surgical procedures. By prioritizing innovation and clinical efficacy, Apyx Medical provides physicians with the tools necessary to enhance patient outcomes, effectively bridging the gap between complex engineering and practical healthcare application. Their market position is defined by a commitment to high-performance energy-based technologies that address the evolving requirements of the aesthetic and surgical fields.
How much funding has Apyx raised?
Apyx has raised a total of $25M across 1 funding round:
Debt
$25M
Debt (2023): $25M with participation from MidCap Financial Investment Corporation
Key Investors in Apyx
MidCap Financial Investment Corporation
MidCap Financial Investment Corporation is a specialized investment firm focused on providing debt financing and capital solutions to support the growth and operational needs of corporate entities.
What's next for Apyx?
With the infusion of this recent capital, Apyx Medical is poised to scale its manufacturing infrastructure and deepen its research and development initiatives. The strategic focus will likely shift toward optimizing product distribution channels and expanding the reach of their energy-based surgical platforms. As the company navigates this growth phase, the emphasis remains on maintaining technological superiority and capturing additional market share within the high-growth cosmetic surgery segment. This financial backing provides the necessary liquidity to sustain long-term innovation cycles and support the company's broader enterprise-level objectives.
See full Apyx company page
